Business StrategyPerrigo is streamlining its operations to concentrate on the profitable self-care market, which is enhanced by the strategic sale of their rare disease portfolio, allowing for focused growth and improved financial health.
Operational EfficiencyPerrigo's 'Project Energize' aims to significantly boost operational efficiency, promising substantial cost savings that could enhance profitability and shareholder value.
Product CoveragePerrigo gains a competitive edge as CVS Health plans to cover its oral contraceptive, Opill, potentially setting a precedent for broader market adoption and sales momentum.